Michelle A Malcolmson, MD
Internal Medicine · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 21 years
- Graduated 2005
Offices
2 locations
Looking this up.
Hospitals listed: Alta Bates Summit Medical Center · Alta Bates Summit Medical Center - Alta Bates Camp · Stanford Health Care. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Malcolmson’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A98339 · Current
Licensed to practise in California · since 2006 · expires 2026-10-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Alta Bates Summit Medical CenterOakland, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.09 (87.72 to 172.46) · 109 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.274, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.227, Oct 2024 – Sep 2025
- Alta Bates Summit Medical Center - Alta Bates CampBerkeley, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.298, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Alta Bates Summit Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 0 worse of 7 measures. Readmissions: 3 better, 6 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.09 (87.72 to 172.46) · 109 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.274 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.227 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.94) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.6 to 1.16) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.9 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.8 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 341 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.2 · 381 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 2,811 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,167 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,659 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.93 (0.92 to 4.94) · 1,668 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.25 (0 to 2.75) · 580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.67 (1.19 to 4.15) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.17 (0.33 to 12.02) · 633 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 8.11 (4.67 to 11.55) · 619 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.07) · 309 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 6,085 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 217 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.724 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.425 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.7 · 416 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 606 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.4 · 359 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.8 · 555 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -14.4 · 358 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16 · 382 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.3 to 16) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 56 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.8 (11.1 to 20) · 251 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 579 cases | No different | Jan 2024 – Dec 2024 |
What patients said (535 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Alta Bates Summit Medical Center - Alta Bates Camp
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 6 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.298 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.18 (0.16 to 2.2) · 730 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.51 to 1.23) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.12 (132.31 to 243.94) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 50 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 189 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 103 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,585 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,929 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,954 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.15 (0.95 to 5.36) · 754 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.33) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.99 (0.39 to 3.59) · 717 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.85 (2.27 to 19.44) · 326 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.79 (1.08 to 8.49) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.19 to 3.18) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.17 (0 to 0.88) · 3,240 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 161 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.207 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.48 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.785 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 243 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -58.2 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.3 · 177 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 209 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.4 (3.8 to 7.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.2 (9.4 to 15.5) · 215 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.2 · 81 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (10 to 18.1) · 315 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 15% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 62% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 67% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 38% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Medicaid work
$7,381 in 2019
Medicaid paid $7,381 for 187 billed services this clinician did in 2019, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFF/OP EST MAY X REQ PHY/QHP | 115 | $3,860 |
| Return visit (30+ min) | 72 | $3,521 |
| 2019 | 187 | 2 | 22 | $7,381 |
| 2018 | 244 | 5 | 23 | $8,215 |
See the largest Medicaid services in earlier years
2018
| OFF/OP EST MAY X REQ PHY/QHP | 161 | $5,541 |
| Return visit (30+ min) | 31 | $1,534 |
| New patient visit (30+ min) | 12 | $686 |
| Thyroid stimulating hormone (TSH) | 13 | $253 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 27 | $201 |
Drugs they prescribed that Part D paid
$678
Pharmacies billed $678 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 15) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
15 generic and 0 brand-name prescriptions · $678 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 15 | None | 0% (0) | 0% | $678 |
| 2023 | 57 | 34 | 0% (0) | None | $2,604 |
| 2022 | 768 | 135 | 2% (12) | None | $36,684 |
| 2021 | 432 | 116 | None | 15% | $19,203 |
| 2020 | 800 | 114 | None | 16% | $50,370 |
| 2019 | 925 | 124 | None | 16% | $53,506 |
| 2018 | 738 | 128 | 2% (11) | None | $38,811 |
| 2017 | 1,028 | 124 | 2% (16) | 17% | $42,536 |
| 2016 | 1,188 | 118 | 2% (19) | None | $54,974 |
| 2015 | 1,043 | 104 | 1% (14) | 20% | $54,619 |
| 2014 | 972 | 101 | 2% (16) | None | $60,430 |
| 2013 | 683 | 73 | None | None | $38,990 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 17 drugs
| Flovent Hfa | 14 | $6,159 | $440 |
| Synthroid | 25 | $1,953 | $78 |
| Rosuvastatin | 41 | $1,426 | $35 |
| Atorvastatin | 115 | $1,321 | $11 |
| Gabapentin | 26 | $1,165 | $45 |
| Levothyroxine | 67 | $1,124 | $17 |
| Omeprazole | 13 | $536 | $41 |
| Olmesartan Medoxomil | 14 | $516 | $37 |
| Amlodipine Besylate | 44 | $434 | $10 |
| Escitalopram | 12 | $390 | $32 |
| Alendronate | 28 | $381 | $14 |
| Lisinopril | 52 | $327 | $6 |
| Tamsulosin | 13 | $319 | $25 |
| Pravastatin | 13 | $297 | $23 |
| Fluticasone Propionate | 11 | $212 | $19 |
| Hydrocodone-Acetaminophen | 12 | $113 | $9 |
| Metformin | 15 | $98 | $7 |
2021: 10 drugs
| Synthroid | 17 | $1,312 | $77 |
| Rosuvastatin | 19 | $765 | $40 |
| Levothyroxine | 36 | $737 | $20 |
| Atorvastatin | 35 | $560 | $16 |
| Duloxetine | 12 | $399 | $33 |
| Gabapentin | 16 | $271 | $17 |
| Lisinopril | 29 | $243 | $8 |
| Fluticasone Propionate | 13 | $206 | $16 |
| Amlodipine Besylate | 27 | $198 | $7 |
| Alendronate | 14 | $147 | $11 |
2020: 18 drugs
| Advair Hfa | 14 | $7,304 | $522 |
| Synthroid | 20 | $2,024 | $101 |
| Duloxetine | 23 | $2,010 | $87 |
| Rosuvastatin | 37 | $1,963 | $53 |
| Levothyroxine | 77 | $1,884 | $24 |
| Atorvastatin | 67 | $1,220 | $18 |
| Bupropion Xl | 13 | $755 | $58 |
| Metoprolol | 18 | $527 | $29 |
| Lisinopril | 47 | $470 | $10 |
| Pravastatin | 16 | $457 | $29 |
| Diclofenac | 14 | $360 | $26 |
| Alendronate | 38 | $327 | $9 |
| Montelukast | 15 | $250 | $17 |
| Gabapentin | 22 | $237 | $11 |
| Escitalopram | 12 | $216 | $18 |
| Fluticasone Propionate | 16 | $174 | $11 |
| Amlodipine Besylate | 30 | $163 | $5 |
| Metformin | 17 | $121 | $7 |
2019: 23 drugs
| Shingrix | 18 | $2,940 | $163 |
| Rosuvastatin | 21 | $1,764 | $84 |
| Synthroid | 24 | $1,659 | $69 |
| Levothyroxine | 63 | $1,594 | $25 |
| Atorvastatin | 80 | $1,466 | $18 |
| Amlodipine Besylate | 70 | $926 | $13 |
| Olmesartan Medoxomil | 13 | $800 | $62 |
| Lisinopril | 76 | $667 | $9 |
| Metoprolol | 18 | $640 | $36 |
| Montelukast | 31 | $478 | $15 |
| Pravastatin | 15 | $420 | $28 |
| Duloxetine | 11 | $389 | $35 |
| Alendronate | 39 | $362 | $9 |
| Gabapentin | 30 | $336 | $11 |
| Ibandronate | 11 | $301 | $27 |
| Spironolactone | 15 | $258 | $17 |
| Omeprazole | 12 | $204 | $17 |
| Losartan | 12 | $180 | $15 |
| Metformin | 20 | $175 | $9 |
| Escitalopram | 11 | $113 | $10 |
| Simvastatin | 12 | $98 | $8 |
| Citalopram Hbr | 12 | $92 | $8 |
| Cyclobenzaprine | 11 | $83 | $8 |
2018: 14 drugs
| Atorvastatin | 68 | $1,395 | $21 |
| Levothyroxine | 41 | $1,211 | $30 |
| Montelukast | 29 | $570 | $20 |
| Amlodipine Besylate | 59 | $470 | $8 |
| Metoprolol | 13 | $465 | $36 |
| Ibandronate | 15 | $435 | $29 |
| Lisinopril | 48 | $420 | $9 |
| Nifedipine Er | 11 | $374 | $34 |
| Pravastatin | 12 | $294 | $25 |
| Alendronate | 35 | $273 | $8 |
| Gabapentin | 12 | $239 | $20 |
| Metformin | 24 | $220 | $9 |
| Losartan | 20 | $204 | $10 |
| Pantoprazole | 11 | $193 | $18 |
2017: 22 drugs
| Levothyroxine | 93 | $2,608 | $28 |
| Atorvastatin | 110 | $2,101 | $19 |
| Synthroid | 37 | $1,586 | $43 |
| Ibandronate | 12 | $1,193 | $99 |
| Duloxetine | 22 | $824 | $37 |
| Amlodipine Besylate | 100 | $745 | $7 |
| Montelukast | 32 | $660 | $21 |
| Lisinopril | 62 | $565 | $9 |
| Alendronate | 53 | $528 | $10 |
| Pantoprazole | 42 | $479 | $11 |
| Gabapentin | 17 | $463 | $27 |
| Metoprolol | 17 | $447 | $26 |
| Losartan | 37 | $381 | $10 |
| Fluticasone Propionate | 14 | $325 | $23 |
| Valacyclovir | 20 | $303 | $15 |
| Trazodone | 14 | $181 | $13 |
| Venlafaxine Hcl Er | 15 | $159 | $11 |
| Escitalopram | 11 | $143 | $13 |
| Simvastatin | 13 | $133 | $10 |
| Doxycycline Monohydrate | 11 | $114 | $10 |
| Metformin | 23 | $114 | $5 |
| Hydrocodone-Acetaminophen | 11 | $94 | $9 |
2016: 23 drugs
| Amitiza | 12 | $4,025 | $335 |
| Atorvastatin | 102 | $2,141 | $21 |
| Synthroid | 48 | $2,059 | $43 |
| Levothyroxine | 80 | $1,980 | $25 |
| Valsartan | 14 | $1,847 | $132 |
| Ibandronate | 19 | $1,609 | $85 |
| Duloxetine | 26 | $1,078 | $41 |
| Metoprolol | 19 | $805 | $42 |
| Lisinopril | 86 | $779 | $9 |
| Amlodipine Besylate | 125 | $755 | $6 |
| Alendronate | 54 | $662 | $12 |
| Montelukast | 30 | $588 | $20 |
| Pantoprazole | 42 | $494 | $12 |
| Metformin | 40 | $349 | $9 |
| Losartan | 35 | $343 | $10 |
| Fluticasone Propionate | 12 | $318 | $27 |
| Simvastatin | 24 | $312 | $13 |
| Trazodone | 17 | $243 | $14 |
| Escitalopram | 17 | $223 | $13 |
| Venlafaxine Hcl Er | 20 | $190 | $10 |
| Gabapentin | 13 | $173 | $13 |
| Hydrocodone-Acetaminophen | 13 | $170 | $13 |
| Citalopram Hbr | 21 | $139 | $7 |
2015: 24 drugs
| Atorvastatin | 75 | $1,958 | $26 |
| Valsartan | 16 | $1,914 | $120 |
| Synthroid | 44 | $1,769 | $40 |
| Levothyroxine | 64 | $1,698 | $27 |
| Duloxetine | 11 | $1,668 | $152 |
| Amlodipine Besylate | 108 | $974 | $9 |
| Metoprolol | 27 | $931 | $34 |
| Lisinopril | 78 | $673 | $9 |
| Valacyclovir | 15 | $668 | $45 |
| Pantoprazole | 52 | $520 | $10 |
| Alendronate | 36 | $404 | $11 |
| Montelukast | 21 | $392 | $19 |
| Omeprazole | 13 | $380 | $29 |
| Venlafaxine Hcl Er | 22 | $328 | $15 |
| Liothyronine | 15 | $327 | $22 |
| Ciclopirox | 11 | $320 | $29 |
| Fluticasone Propionate | 14 | $224 | $16 |
| Gabapentin | 24 | $214 | $9 |
| Metformin | 40 | $204 | $5 |
| Clopidogrel | 20 | $177 | $9 |
| Simvastatin | 18 | $166 | $9 |
| Cephalexin | 14 | $78 | $6 |
| Amoxicillin | 13 | $53 | $4 |
| Citalopram Hbr | 11 | $53 | $5 |
2014: 18 drugs
| Diovan | 23 | $5,591 | $243 |
| Synthroid | 46 | $1,867 | $41 |
| Amlodipine Besylate | 125 | $1,499 | $12 |
| Atorvastatin | 64 | $1,424 | $22 |
| Metoprolol | 39 | $1,217 | $31 |
| Levothyroxine | 56 | $1,170 | $21 |
| Montelukast | 20 | $831 | $42 |
| Lisinopril | 69 | $501 | $7 |
| Omeprazole | 26 | $380 | $15 |
| Alendronate | 29 | $313 | $11 |
| Pantoprazole | 24 | $276 | $11 |
| Venlafaxine Hcl Er | 15 | $266 | $18 |
| Simvastatin | 21 | $251 | $12 |
| Clopidogrel | 16 | $200 | $13 |
| Diclofenac | 18 | $118 | $7 |
| Metoprolol | 13 | $100 | $8 |
| Metformin | 11 | $81 | $7 |
| Citalopram Hbr | 11 | $76 | $7 |
2013: 16 drugs
| Azor | 19 | $6,643 | $350 |
| Actonel | 13 | $3,082 | $237 |
| Diovan | 13 | $2,014 | $155 |
| Atorvastatin | 49 | $1,817 | $37 |
| Amlodipine Besylate | 113 | $1,191 | $11 |
| Metoprolol | 38 | $1,160 | $31 |
| Synthroid | 30 | $1,036 | $35 |
| Levothyroxine | 43 | $562 | $13 |
| Lisinopril | 71 | $485 | $7 |
| Simvastatin | 20 | $325 | $16 |
| Omeprazole | 22 | $256 | $12 |
| Pantoprazole | 11 | $245 | $22 |
| Losartan | 13 | $220 | $17 |
| Clopidogrel | 13 | $191 | $15 |
| Alendronate | 11 | $187 | $17 |
| Citalopram Hbr | 11 | $119 | $11 |
Money from drug and device companies
$19 in 2022
A payment is not proof that care is biased.
| iRhythm Technologies | Zio Xt Patch | $19 | 1 payment
|
See the published payment
| iRhythm Technologies | Meals · 2022-11-16 | Zio Xt Patch | $19 |
Professional record
- NPI
- 1164602082
- Licence
- CA A98339California A98339: Current · expires 2026-10-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 6121 Hollis St Ste 400, Emeryville, CA, 94608
- NPI first listed
- 2007-11-08
- NPI last updated
- 2025-01-09
- NPI record certified
- 2025-01-09
This is when the NPI record was last certified, not a medical board exam.